BackGwo Xi Stem Cell Applied Technology , Ltd Overview

Gwo Xi Stem Cell Applied Technology , Ltd Long Term Debt

Gwo Xi Stem Cell Applied Technology , Ltd's long-term debt is $270M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$268.87M
↓ 11.72% YoYΔ $-35.71M vs prior year quarter

Peer trimmed avg / median

Loading

Gwo Xi Stem Cell Applied Technology , Ltd Long Term Debt History

Loading

Gwo Xi Stem Cell Applied Technology , Ltd vs. peers: Long Term Debt Comparison

Loading

Gwo Xi Stem Cell Applied Technology , Ltd Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) FAQ

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) currently reports a long-term debt of $270M as of June 2026. That compares with $300M in the prior-year period — down 11.7% year over year. Use the charts on this page to explore Gwo Xi Stem Cell Applied Technology , Ltd's long-term debt history and peer comparisons.

Gwo Xi Stem Cell Applied Technology , Ltd's long-term debt decreased from $300M to $270M — a 11.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gwo Xi Stem Cell Applied Technology , Ltd reported $270M in long-term debt as of June 2026. That compares with $300M in the prior-year period — down 11.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $270M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gwo Xi Stem Cell Applied Technology , Ltd, and consider following 6704.TWO for alerts when major investors trade the stock.

Gwo Xi Stem Cell Applied Technology , Ltd is classified in the Healthcare sector. On long-term debt, it currently shows $270M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6704.TWO with unrelated industries.